10/2/2013 6:42:48 AM
Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Guillaume Pfefer, Ph.D., Kala’s President and Chief Executive Officer, is scheduled to provide a corporate update at the 12th Annual BIO Investor Forum being held October 8-9, 2013 at the Palace Hotel in San Francisco, CA. Dr. Pfefer’s presentation will take place on Tuesday, October 8, 2013 at 11:45 a.m. PT in the Marina room.
Help employers find you! Check out all the jobs and post your resume.
comments powered by